White House says food, toxins among reasons for poor U.S. health
The White House blamed exposure to environmental toxins, poor nutrition, and increased screen time for a decline in Americans' life expectancy Thursday, in a major administration report that also casts doubt on the current vaccine schedule and medications deemed safe by most in mainstream medicine.
The 'MAHA Report: Making Our Children Healthy Again," authored by Cabinet officials and administration scientific leaders in response to a President Donald Trump executive order, declared that 'today's children are the sickest generation in American history in terms of chronic disease.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
26 ZAZA THCA Flower Strains Unleashed: The Hemp Doctor's Largest Drop Yet
MOORESVILLE, N.C., June 26, 2025 (GLOBE NEWSWIRE) -- The Hemp Doctor, America's premier hemp and cannabinoid brand, introduces its largest THCA flower collection release with 26 indoor-grown unique strains handpicked for exceptional quality, flavor, and potency. This new wave of Farm Bill-compliant ZAZA THCA Flower offers consumers some of the most exotic and sought-after cultivars on the market today. Selected for their high THCA content, boutique genetics, bag appeal, and loud terpene profiles, all 26 strains reflect the qualities of what you call a Zaza. The 26 ZAZA Strains Include: 1. Mr. Nasty 2. Obama Runtz 3. Cali-O 4. Watermelon Z 5. Cocolato 6. Martian Candy 7. Gas 8. Cat Piss 9. Hawaiian 10. Orange Creamsicle 11. Stardog Guava 12. Elektro Ice Candy 13. Georgia Pie x Gastro Pop 14. Califire OG 15. Forbidden Runtz 16. Sharpie 17. Candyland 18. Modified Grapes 19. Jello Cake (Living Soil) 20. Slurty 21. Sweet Tarts 22. Donny Burger 23. Gelato (Living Soil) 24. Super Boof 25. Skunk 26. Sweet Island Skunk Of the 26 ZAZA strains, 10 are indicas, 7 are sativas, and 9 are hybrids. With this many options per strain type, consumers have a wide range to choose from, spanning from relaxation-heavy to energizing and balanced effects. What Makes This ZAZA Different? Every flower in this drop is indoor-grown and cultivated using living soil methods, a practice that enhances cannabinoid and terpene expression for richer flavor, deeper aroma, and overall higher quality. These organically grown buds are produced on US-based farms, meeting federal guidelines for hemp-derived products. With lab-verified THCA content averaging from 20–35%, this release stands as a top-tier option for seasoned cannabis consumers. Some of the highest THCA levels recorded in this flower collection exceed 35%, particularly in standout strains like Elektro Ice Candy and Sweet Tarts. 'Our Zaza THCA flower reflects our ongoing commitment to bridge the gap between high-end cannabis and compliant hemp,' said Robert Shade, Founder of The Hemp Doctor. 'Our customers are looking for a variety of strains, strengths, and terpene-rich experiences, and this collection delivers all that and more.' From relaxing indicas to uplifting sativas and potent hybrids, all strains are lab-tested, with results accessible to the public. Every hand-trimmed and slowly cured batch is screened for cannabinoid potency, pesticide residues, heavy metals, microbial contamination, etc. All 26 THCA strains in this launch are now available for purchase at Orders are shipped discreetly and in compliance with regulations across most U.S. states where THCA is permitted. For wholesale orders, visit Check our products up close and personal at The Hemp Doctor stores located in Huntersville, Mooresville, and Concord, North Carolina. About The Hemp Doctor The Hemp Doctor has been providing quality hemp-derived products since 2018. The North Carolina-based company is known for offering cannabinoid products ranging from the best THCA flower to pre-rolls, concentrates, gummies, vapes, and more. The company stands out for its dedication to producing quality products at par with customer satisfaction. With over 100,000 satisfied returning customers, thousands of subscribers, 5,000+ five-star Yotpo reviews, and a Trustpilot rating of 4.6 out of 5 stars, The Hemp Doctor has positioned itself as a leader in the industry. As a company strictly adhering to lawful and safe human consumption, The Hemp Doctor's array of products undergoes third-party DEA-certified lab testing. For media inquiries, interviews, or additional information, please contact: Tara Phoenixtara@ 917-797-8347 A photo accompanying this announcement is available at in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Cigna Enhances myCigna Platform With AI Assistant, Personalized Care, Cost Tools
The Cigna Group (NYSE:CI) is one of billionaire Leon Cooperman's top stock picks with huge upside potential. On June 12, Cigna Healthcare, the health benefits arm of The Cigna Group (NYSE:CI), revealed new digital capabilities designed to enhance the consumer experience during routine health insurance interactions. The myCigna member interface will be used to gradually roll out the new technologies, which include a virtual assistant driven by AI, personalized provider matching, real-time cost tracking, intelligent claim submission, and assistance with plan selection. The AI-powered virtual assistant offers tailored responses to inquiries concerning benefits, claims, and available care options, according to Cigna Healthcare. According to preliminary findings, more than 80% of clients who had access to the virtual assistant found it useful. Additionally, in order to help customers with complicated health needs have their administrative problems resolved more quickly, The Cigna Group (NYSE:CI) is investing in centralized agent teams and increasing access to dedicated My Personal Champion advocates. The Cigna Group (NYSE:CI) specializes in providing insurance and associated services in the United States, such as pharmaceutical benefits, home delivery pharmacy, and specialty pharmacy distribution. While we acknowledge the potential of CI as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Medscape
an hour ago
- Medscape
Photo App Could Spot Anemia in Seconds
Artificial intelligence (AI) plays an increasingly prominent role in the workplace, and health researchers are exploring its potential to improve the diagnosis and treatment of diseases. In this context, the company Sanguina Inc., based in the US, has developed an app called Ruby Health, designed to help detect anemia using just a photo of a patient's fingernails. Currently available for Android and iOS devices in the US, the app's effectiveness was detailed in a study published by Sanguina's research team in the journal PNAS . The study and the companion tool grew out of an academic project launched in 2015 by Wilbur Lam, Erika Tyburski, and Rob Mannino. 'The development was rigorous. The idea came from the fact that, for decades, we have known that patients with anemia have paleness in some parts of the body, such as their fingernails, so we thought about the possibility of a noninvasive method, such as an app, to measure this paleness without having to draw blood,' said Lam, a researcher at Emory University School of Medicine in Atlanta, Georgia. Since its launch in 2021, Ruby Health has registered 1.4 million users in the US upload fingernail photos to estimate hemoglobin (Hgb) levels and may manually enter the lab results. Researchers then compare estimated Hgb with blood-test values to gauge accuracy. Among individuals with Hgb between 7 g/dL and 17 g/dL, the mean absolute error was ±0.72 g/dL. Using an Hgb cutoff of 12.5 g/dL to define anemia, the application demonstrated a sensitivity of 89% and a specificity of 93%. For Lam, this tool is promising. 'Based on the values entered, when calibrated, our app works similarly to blood-based methods. With 'homemade' methods, there is always the concern that they do not translate to what is tested in the lab, but we demonstrated the usability of the platform by replicating data in a closed clinical environment and in the real world,' he said. The platform's personal records feature allows for the personalization of treatment tips for patients, and geolocation data helps map cases for the application of public policies and the allocation of treatment resources. However, Ruby Health has limitations: It does not detect very low Hgb levels (< 7 g/dL) and cannot identify the type of anemia the patient has, which is crucial for determining treatment. 'Anemia is not a disease itself but a condition secondary to many illnesses,' said Helena Zerlotti Wolf Grotto, MD, professor of Clinical Pathology at Universidade Estadual de Campinas, Campinas, Brazil, laboratory-hematology consultant, and member of the Brazilian Association of Hematology. 'To determine the cause of anemia, it is necessary to perform tests, evaluate the patient's history and perform a physical examination, since treatment involves comprehensive care,' she said. The gold standard for diagnosing anemia remains the complete blood count, which identifies the type of anemia and its possible causes. 'Screening tests like this app could be useful in remote or resource‐limited areas,' Grotto added. However, in the United States, the app was more widely adopted in areas with higher average incomes, better access to primary care, and a higher proportion of Black residents. In Brazil, Grotto sees limited benefit in urban centers with broad access to laboratory tests, as the public health system already provides robust anemia testing. She is also concerned about accuracy in Black patients, since AI tools often lack adequate training to identify darker skin tones, which could hinder the app's functionality among Brazilians or other mixed-race populations. However, Lam stated that the app's algorithm has been tested on different skin tones and that nails have a lower amount of melanin, which minimizes the variability in skin color from one person to another. Although not 100% accurate, the app can be used to indicate the possibility of a person having anemia in certain cases, according to experts. The developers themselves have stated that it is not suitable for emergency clinical decision-making. 'The market is full of innovations, but we must remain critical before assuming they will solve every problem,' Grotto said.
